Postcomparison of [(18) F]-fluorodeoxyglucose uptake in the brain after short-term bright light exposure and no intervention.

OBJECTIVE: Bright light therapy is widely used as the treatment of choice for seasonal affective disorder. Nonetheless, our understanding of the mechanisms of bright light is limited and it is important to investigate the mechanisms. The purpose of this study is to examine the hypothesis that bright light exposure may increase [(18) F]-fluorodeoxyglucose (FDG) uptake in olfactory bulb and/or hippocampus which may be associated neurogenesis in the human brain. METHOD: A randomized controlled trial comparing 5-day bright light exposure + environmental light (bright light exposure group) with environmental light alone (no intervention group) was performed for 55 participants in a university hospital. The uptake of [(18) F]FDG in olfactory bulb and hippocampus using FDG positron emission tomography was compared between two groups. RESULTS: There was a significant increase of uptake in both right and left olfactory bulb for bright light exposure group vs. no intervention group. After adjustment of log-transformed illuminance, there remained a significant increase of uptake in the right olfactory bulb. CONCLUSION: The present findings suggest a possibility that 5-day bright light exposure may increase [(18) F]FDG in the right olfactory bulb of the human brain, suggesting a possibility of neurogenesis. Further studies are warranted to directly confirm this possibility.

Effect of Garcinia cambogia extract on serum leptin and insulin in mice.

In this study we examined the effects of 3.3% Garcinia cambogia extract on 10% sucrose loading in mice for 4 weeks. Treatment was found to have no effect on body weight, fat pad weight or serum glucose level. On the other hand, serum total cholesterol, triglycerides, NEFA were observed. Levels of serum insulin and leptin, as well as the leptin/WAT ratio, were lower in the treated mice than in the control. These findings suggested that G. cambogia extract efficiently improved glucose metabolism and displayed leptin-like activity.

[Follow-up survey of dioxins in the blood of Yusho patients (in 1998-1999)].

Follow-up survey of the blood concentration of PCDDs, PCDFs and non-ortho-chlorine substituted PCBs in Yusho patients is very important for their health control. We determined the blood concentration of these dioxin isomers in 119 blood samples collected in 1998 and 1999 using by a high-resolution gas chromatograph/high-resolution mass spectrometry (HRGC/HRMS). Thirty years had passed since the Yusho occurrence, and the total blood concentrations of PCDFs in the blood of Yusho patients were still as high as ever, except the patients with the PCB pattern C. Among the different groups of PCB patterns, the concentration of 2,3,4,7,8-PeCDF, 1,2,3,4,7,8-HxCDF and 1,2,3,6,7,8-HxCDF showed significant differences, excluding the group BC because of the small number of cases. The findings indicate that these isomers are not decomposed in human body since they had highly contaminated the causal rice oil at the onset. In typical Yusho patients (Group A of PCB pattern), the mean TEQ concentrations of PCDDs, PCDFs and non-ortho-chlorine substituted PCBs in the blood collected in 1998 were 21, 206, and 14 pg-TEQ/g lipid, respectively, and in 1999, 30, 308 and 14 pg-TEQ/g lipid, respectively. The toxic contribution rate of PCDFs TEQ was still at high levels for total TEQ in both years. The patients of the group C, however, the mean blood levels of the dioxins TEQ in 1998 and 1999 did not differ from those of the normal controls determined in 1996 although some patients in this group showed a high toxic contribution rate of PCDFs TEQ for total TEQ. We will try the PCB isomer specific analysis of the Yusho patients blood, and will investigate the difference from normal controls blood.

[Blood PCB analysis by capillary column-gas chromatograph/quadruple mass spectrometer--comparison with packed column-electron capture detector/gas chromatograph].

The contents of polychlorinated biphenyls (PCBs) in the blood of Yusho patients (Y) and normal subjects (N) were analyzed, using a gas-chromatograph equipped with a capillary column/quadruple mass spectrometer (capillary column GC/MS). While the average of the content of blood PCBs was 679 ppt in N, those were 2960, 1480 and 1090 ppt in Y diagnosed previously as A, B and C patterns, respectively. The contents of non-ortho coplanar PCBs (3,3',4,4' Tetra-, 3,3',4,4',5-Penta- plus 3,3',4,4',5,5'-Hexa-CB) were 0.9-2.1 ppt in Y, and 0.8 ppt in N. The contents of eight mono-ortho coplanar PCBs having the toxic equivalency factors (TEFs) were 118-424 (Y) and 78 ppt (N), respectively. The differences between Y and N in the species of mono-ortho coplanar PCBs contained were observed as follows: 2,3,3',4,4',5- and 2,3,3',4,4',5'-Hexa-CB were predominant in Y, whereas 2,3,4,4',5-Penta-CB was a major congener in N. The levels of di-ortho coplanar PCBs (2,2',3,4,4',5,5' plus 2,2',3,3',4,4'5-Hepta-CB) were determined to be 195-608 and 98 ppt in Y and N, respectively. In both groups, the content of the former isomer was greater than the latter. Total TEQ values were 0.214-1.226 ppt in Y, and 0.148 ppt in N. The analyses were also performed by a conventional method in which a GC equipped with a packed column/electron capture detector (packed column GC/ECD) was used, and the results obtained were compared with those by capillary column GC/MS method. The results showed that the total PCB levels obtained by capillary column GC/MS method were 56-61% in Y and 67% in N of those obtained by packed column GC/ECD method.

The effects of crossed olivocochlear bundle section on transient evoked otoacoustic emissions.

The purpose of this study was to investigate the effect of sectioning the crossed olivocochlear bundle (COCB) on transient evoked otoacoustic emissions (TEOAEs) in anesthetized adult chinchillas. Of particular interest is the role of cochlear efferents to the outer haircells (OHCs) and how they control mechanisms responsible for otoacoustic emissions. Specifically the experiment addressed whether a tonic level of inhibitory control is reduced by COCB section. The nonlinear component of TEOAEs was measured before and after COCB section. Analysis was made of the 1, 2, 3, 4, and 5 kHz frequency components and of the total emission, as quantified by fast Fourier transform (FFT) of the raw (time domain) response. After COCB section, the amplitude of the total response and of the 2, 3, 4, and 5 kHz components increased whereas the amplitude of the 1 kHz component decreased. The results indicate that COCB section reduces inhibitory control of the OHC mechanisms responsible for nonlinear TEOAE generation. It is not clear whether the nerve section eliminates a spontaneous level of activity in COCB efferents, or whether it results in the interruption of a stimulus-evoked feedback loop.

[Concentrations of PCDDs, PCDFs and coplanar PCBs in blood of 83 patients with Yusho].

Concentrations of polychlorinated dibenzo-p-dioxins (PCDDs), polychlorinated dibenzofurans (PCDFs), coplanar polychlorinated biphenyls (Co-PCBs) and total polychlorinated biphenyls (PCBs) were analyzed in blood samples from 83 Yusho patients and 39 normal control subjects in 1995. The average concentrations of PCDDs, PCDFs and Co-PCBs in the blood of Yusho patients were 14, 128 and 14 pg toxic equivalent quantity (TEQ)/g, lipid, respectively. The levels of these compounds in the blood of normal subjects were 14, 10 and 8 pg/g lipid, respectively. Thus, although the average levels of PCDDs and Co-PCBs in the blood of Yusho patients were similar to those of control subjects, the PCDF level in Yusho patients was 12.8 fold higher than in normals. Average concentrations of total PCBs in the blood of Yusho patients and normal control subjects were 789 and 339 ng/g lipid, respectively. Thus, the PCB level in the blood of Yusho patients was 2.3 fold higher than in normal subjects. To test the reproducibility of determination of PCDDs, PCDFs and Co-PCBs, three normal blood samples were analyzed twice. These analyses gave similar results each time. Since, these compounds could be measured in five-milliliter blood samples, they can be monitored in Yusho patients.

[Levels of PCDDs, PCDFs and coplanar PCBs in sebum and blood of Yusho patients].

Polychlorinated dibenzo-p-dioxins (PCDDs) and it's related compounds such as polychlorinated dibenzofurans (PCDFs) can be detected in the body in Yusho patients, a condition caused by ingestion of contaminated rice oil with these compounds. These compounds are excreted out of the body in small amounts directly in the feces from the wall of the intestine. We found the PCDDs, PCDFs and coplanar polychlorinated biphenyls (Co-PCBs) in the sebum of Yusho patients and normal subjects, and there was significant correlation between their concentrations in sebum and blood in both patients and normal control subjects. The concentration of TEQ (toxic equivalent quantity of 2,3,7,8-tetrachlorodibenzo-p-dioxin: TCDD) in sebum of Yusho patients (106 pg/g lipid) was half that in the blood (215 pg/g lipid), while that of normal subjects (29 pg/g lipid) was similar to that in the blood (34 pg/g lipid). On the other hand, in Yusho patients the concentrations of TEQ in the sebum and in blood were 2.3 and 6.4 fold higher than those in normal subjects. We concluded that dioxins and it's related compounds in Yusho patients and normal subjects were excreted not only in the feces but also in the sebum.

[Stimulation for sebum excretion of PCDDs, PCDFs and coplanar PCBs on bathing ceramic sand bath].

We previously reported that high risk environmental contaminants such as polychlorinated dibenzo-p-dioxins (PCDDs), polychlorinated dibenzofurans (PCDFs) and coplanar polychlorinated biphenyls (PCBs) are excreted not only in feces but also in the sebum of the face and body in both normal subjects and Yusho patients. A combination of administration of rice bran fiber and cholestyramine increased fecal excretion of PCDFs and PCBs. In the present study, we stimulated excretion of these compounds in sebum using a ceramic sand bath, a kind of sand bath using small ceramic balls (3.5 mm diameter) instead of natural sand. Five normal volunteers participated in this experiment. Sebum eliminated from the body on bathing ceramic sand bath was collected and weighed and then concentrations of the compounds interest in the sebum were determined. We also examined the effects varying the bath conditions such as temperature of sand, length of bathing time and frequency of taking bath on the amounts of the compounds in the eliminated sebum. The results can be summarized as follows: 1. The average amount of sebum per one bath eliminated from the body during the ceramic sand bath was 0.252 g, and those of PCDDs, PCDFs and coplanar PCBs in it were 2.2, 2.0 and 2.2 pg of TEQ (2,3,7,8-tetrachlorodibenzo-p-dioxin equivalent quantity). It was considered that the amounts of these compounds corresponded to between one quarter and third of those eliminated through the sebum in a day. On the other hand, 0.05 g of the sebum was collected from the face during the bath, included 0.39, 0.39 and 0.59 pg TEQ for PCDDs, PCDFs and coplanar PCBs, respectively. 2. As the number of bathing times a day increased, the amount of sebum per bath gradually decreased. However, we could not determine the influence of the conditions of the bath such as temperature and time.

Efficacy of nutritional therapy for active Crohn's disease.

We investigated the effect of nutritional therapy with an elemental diet (ED) for active Crohn's disease. One hundred and thirty-nine patients with Crohn's disease were enrolled in this study. Remission was judged to be present when the International Organization of Inflammatory Bowel Disease score was < or = 1 and the CRP and ESR values were within the respective normal ranges. An amount of 30kcal per 1kg of ideal body weight (IBW) per day was administered enterally, and the effect on the induction of remission in relation to various patient background factors, such as disease type, history of bowel resection, and the presence/absence of complications, was determined. An excellent remission rate was achieved in those patients to whom an adequate amount of ED could be administered. Remission rates were lower in the patient groups with any of the following complications: stenotic bowel lesions, abdominal masses, fistulas, and anal lesions. Even in those groups in which stenotic lesions or abdominal masses were present, when adequate amounts of ED could be administered, the remission rate did not differ from that in the groups without these complications. The remission rates in the groups with and without fistulas at any site, including fistulas in the anal region, were 40.0% and 82.5%, respectively, with remission being considerably easier to achieve in the patients without fistulas. Similarly, remission was difficult to achieve when anal lesions were present. These results suggest that, for active Crohn's disease, nutritional therapy with ED ( > or = 35kcal/kg IBW) should be enthusiastically administered, and in patients in whom the presence of complications necessitates therapy for 3 months or more, this point be considered to indicate a possible surgical approach.

Clinical trial of a combination of rice bran fiber and cholestyramine for promotion of fecal excretion of retained polychlorinated dibenzofuran and polychlorinated biphenyl in Yu-Cheng patients.

A clinical trial using the combination of rice bran fiber (RBF) and cholestyramine (CHO) was carried out on Yu-Cheng patients in 1993-1994. By the analysis of blood and stool samples collected from the patients before and after (or during in the case of stool), it was verified that the administration of RBF and CHO is effective for excretion of polychlorinated biphenyl (PCB) (p < 0.05) and polychlorinated dibenzofuran (PCDF), especially 2, 3, 4, 7, 8-pentachlorodibenzofuran (p < 0.05). However, the degree of effectiveness varied upon individual patients from 60 to 160% for 2, 3, 4, 7, 8-pentachlorodibenzofuran, from 30 to 110% for 1, 2, 3, 4, 7, 8-hexachlorodibenzofuran and from 50 to 190% for PCB, respectively.

[Levels of PCDDs, PCDFs and coplanar PCBs in the blood and stool of Taiwanese Yu-Cheng patients].

Levels of PCDDs, PCDFs and coplanar PCBs were measured in the blood and stool obtained from seventeen patients with Yu-Cheng in Taiwan. The average total concentrations of PCDDs, PCDFs and coplanar PCBs in the blood collected from Yu-Cheng patients in January 1993 and August 1994 were 590 and 570 pg Toxic Equivalents (TEQs)/g lipid, respectively. The concentrations of PCDDs, PCDFs and coplanar PCBs in the blood of patients were 21, 540 and 10 pg TEQs/g fat, respectively. On the other hand, the fecal excretion of PCDDs, PCDFs and coplanar PCBs were 26, 720 and 15 pg TEQs/day, respectively. The composition of congeners in the feces was quite similar to the one in the blood. The half lives were estimated as 9.1 and 8.6 years for 2, 3, 4, 7, 8-pentachlorodibenzofuran and 1, 2, 3, 4, 7, 8-hexachlorodibenzofuran based on fecal excretion, respectively.

Intraoperative evaluation of extent of aganglionosis by a rapid acetylcholinesterase histochemical technique.

Using a supplemental oxidation step, the authors modified the acetylcholinesterase (AChE) histochemistry technique of Karnovsky and Roots to produce staining of cholinergic nerve fibers in 10 minutes rather than in 2 hours, as required with the conventional AChE technique. They examined seromuscular intestinal biopsy specimens taken at three levels (aganglionic, transitional zone, ganglionic) from 10 patients during pull-through operations for Hirschsprung's disease, using the rapid AChE technique in addition to H&E staining. Using the acetylcholinesterase technique, the hypertrophic nerve trunks in the aganglionic segment and ganglion cells in the ganglionic segment stained strongly and were easily noticeable. The authors believe that the rapid AChE technique is a simple and reliable method for intraoperative evaluation of the extent of the aganglionic segment, because it provides quicker and more accurate identification of ganglion cells and hypertrophic nerve trunks in the space between the longitudinal and circular muscle layers of the bowel wall.

A rapid technique of acetylcholinesterase staining.

When tissue samples are evaluated for the presence of Hirschsprung's disease, results of acetylcholinesterase staining are usually more informative than findings from the routine hematoxylin-eosin method. The standard technique for staining acetylcholinesterase takes 2 hours to perform and is based on the enzyme histochemical method of Karnovsky and Roots, with a subsequent visualization step as described by Hanker and colleagues. We modified the technique by the introduction of supplemental oxidation, which accelerated the staining time to less than 10 minutes. When evaluated in 10 patients with Hirschsprung's disease and in seven control patients with normal colons, the rapid technique gave identical staining of nerves and ganglion cells to that of the standard method. Increased visualization of endogenous peroxidase-containing histiocytes occurred, but it was not a diagnostic problem. The technique is sufficiently rapid to be used in conjunction with routine frozen sections to assist in the diagnosis and in selecting the optimal level of resection at the time of definitive surgery.

[Coplanar PCBs, PCDFs and PCDDs in the subcutaneous adipose tissue of Yusho patients and normal controls].

3,4,3',4'-tetrachlorobiphenyl (T4CB), 3,4,5,3',4'-pentachlorobiphenyl (P5CB) and 3,4,5,3',4',5'-hexachlorobiphenyl (H6CB) [Co-PCBs] in the subcutaneous adipose tissue of seven Yusho patients and eight normal controls were determined to assess the contribution in the risk caused by the Yusho causual agents (PCBs, PCDFs, PCDDs and Co-PCBs) by using high resolution gas chromatography/high resolution mass spectrometry in selected ion monitoring mode. 3,4,3',4'-T4CB, 3,4,5,3',4'-P5CB and 3,4,5,3',4',5'-H6CB were detected in the subcutaneous adipose tissue of the Yusho patients at the levels, of 6 to 29 ppt, of 32 to 130 ppt and of 160 to 1,140 ppt, respectively. The TCDD-Eq (Equivalents) value calculated by TCDD-TEfs (Toxic Equivalent factors) was from 8 to 30 ppt. On the other hand, 3,4,3',4'-T4CB, 3,4,5,3',4'-P5CB and 3,4,5,3',4',5'-H6CB were detected in the subcutaneous adipose tissue of normal controls at the levels, of 3 to 9 ppt, of 41 to 280 ppt and of 47 to 200 ppt, respectively. The TCDD-Eq value calculated by TCDD-TEfs was from 9 to 57 ppt. In the Yusho patients, the average TCDD-Eq value calculated by TCDD-TEfs of the residual Co-PCBs, PCDFs and PCDDs was 17, 491 and 24 ppt, respectively. Therefore, we concluded that the typical symptoms for the Yusho patients are caused mostly by PCDFs.

[Therapeutic trial for promotion of fecal excretion of PCDFs and PCBs by the administration of cholestyramine in Yusho patients].

Any effective therapy for elimination of causal agents remaining in Yusho patients was not found until now. To know the profile of fecal excretion of polychlorinated dibenzofurans (PCDFs) and polychlorinated biphenyls (PCBs), the amounts of PCDFs and PCBs in the stool of six Yusho patients with the typical symptoms were determined. The stool samples of Yusho patients were collected in 1989. PCDFs, i.e., 2,3,7,8-tetrachlorodibenzofuran (TCDF), 2,3,4,7,8-pentachlorodibenzofuran (PnCDF), 1,2,3,4,7,8- and 1,2,3,6,7,8-hexachlorodibenzofurans (HxCDFs), 1,2,3,4,6,7,8-heptachlorodibenzofuran (HpCDF) and octachlorodibenzofuran (OCDF) were detected in all of the samples. PCDFs found in the stool samples were mostly PnCDF and HxCDFs. Of PCDFs detected, PnCDF and HxCDFs contributed to 42 +/- 4.7% and 43 +/- 5.5% as mean +/- SE, respectively. The fecal excretion of PnCDF and HxCDFs in Yusho patients was 720 +/- 490 pg/day and 790 +/- 620 pg/day as mean +/- SE, respectively. On the other hand, the fecal excretion of PnCDF and HxCDFs in normal controls was 32 +/- 13 pg/day and 47 +/- 5.2 pg/day as mean +/- SE, respectively. The fecal excretion of PnCDF and HxCDFs in Yusho patients was about 23 times and 17 times each higher than that in normal controls. The fecal excretion of PCBs in Yusho patients and normal controls was 400 +/- 430 ng/day and 150 +/- 39 ng/day, respectively, as mean +/- SE. In order to promote the excretion of these toxic chemicals in the stool of Yusho patients, the patients were continuously administered with cholestyramine, an anion exchange resin, at a dose of 4 g, 3 times a day, for 6 months.(ABSTRACT TRUNCATED AT 250 WORDS)

[The effect of an arginine-imbalanced diet on the growth of implanted MM-48 and MH-134 tumors in C3H/He mice].

The arginine-imbalanced diet used in this study was a diet of 27% casein supplemented with 8% arginine monochloride. There was no difference in the serum protein level between C3H/He mice fed a casein diet (N-mice) and mice fed on the arginine-supplemented diet (A-mice). The serum arginine level was increased in the A-mice compared with the N-mice. Significant inhibition of MM-48 tumor incidence was seen in the A-mice when the transplanted tumor was below 5 X 10(6) cells. Growth inhibitory effect against MM-48 tumor was significantly enhanced in the A-mice with i.p. injection of OK-432. Interferon production of spleen cells was increased in the A-mice compared with the N-mice. We speculate that the effect of arginine depends partially on the immune functions in the mice.